Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Subcommittee OKs bill requiring coverage for provider-ordered biomarker testing
Summary
House Bill 484, sponsored by Chairman Martin, was amended and passed by the Insurance Subcommittee to require coverage of provider-ordered biomarker (biomarker) testing for diagnosis and treatment management; supporters said the tests can improve targeted cancer care and reduce long-term costs.
The Insurance Subcommittee voted 6-0 to pass an amended House Bill 484, which requires coverage of provider-ordered biomarker testing when used for diagnosis, treatment, and ongoing management of conditions, according to the sponsor.
"The intent of this bill is pretty simple. It's to get Tennesseans the right treatment at the right time... This bill will ensure that biomarker testing is covered when ordered by…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
